PTC Therapeutics to Present at the 43rd Annual J.P. Morgan Healthcare Conference
PTC Therapeutics to Present at the 43rd Annual J.P. Morgan Healthcare Conference
WARREN, N.J., Dec. 23, 2024 /PRNewswire/ -- PTC Therapeutics, Inc. (NASDAQ: PTCT) today announced that CEO Matthew B. Klein, M.D., will present at the 43rd Annual J.P. Morgan Healthcare Conference on Monday, January 13, 2025, at 11:15 a.m. PST / 2:15 p.m. EST.
新泽西州沃伦，2024年12月23日 /PRNewswire/ -- PTC Therapeutics, Inc. (纳斯达克: PTCT) 今天宣布，首席执行官马修·B·克莱因万.D.将于2025年1月13日星期一上午11:15 PSt / 下午2:15 ESt在第43届摩根大通医疗健康大会上进行演讲。
The presentation will be webcast live on the Events and Presentations page under the Investors section of PTC Therapeutics' website at and will be archived for 30 days following the presentation. It is recommended that users connect to PTC's website several minutes prior to the start of the webcast to ensure a timely connection.
该演讲将通过PTC Therapeutics网站投资者部分的活动和演讲页面进行现场直播， 并将在演讲后存档30天。建议用户在网络直播开始前几分钟连接PTC的官网，以确保及时连接。
About PTC Therapeutics, Inc.
PTC is a global biopharmaceutical company that discovers, develops and commercializes clinically differentiated medicines that provide benefits to children and adults living with rare disorders. PTC's ability to innovate to identify new therapies and to globally commercialize products is the foundation that drives investment in a robust and diversified pipeline of transformative medicines. To learn more about PTC, please visit us at and follow us on Facebook, Instagram, LinkedIn and X.
关于PTC Therapeutics, Inc.
PTC是一家全球药品公司，致力于发现、开发和商业化临床上差异化的药物，为罕见疾病的儿童和成年人提供益处。PTC创新的能力在于识别新的治疗方法并全球商业化产品，这一基础推动着对强大而多元化的变革性药物管线的投资。要了解有关PTC的更多信息，请访问我们的网站，并在Facebook、Instagram、LinkedIn和X上关注我们。
For More Information:
更多信息：
Investors:
Ellen Cavaleri
+1 (615) 618-6228
[email protected]
投资者：
艾伦·卡瓦莱里
+1 (615) 618-6228
[email protected]
Media:
Jeanine Clemente
+1 (908) 912-9406
[email protected]
媒体：
珍妮娜·克莱门特
+1 (908) 912-9406
[email protected]
SOURCE PTC Therapeutics, Inc.
来源 PTC Therapeutics, Inc.
